EssilorLuxottica Acquires 80% Stake in Heidelberg

In July 2024, EssilorLuxottica announced the acquisition of an 80% stake in Heidelberg Engineering, a German ophthalmic technology specialist. The financial details of the transaction have not been disclosed. Under the terms of the acquisition, Heidelberg Engineering will continue to operate independently under its existing brand within the EssilorLuxottica Group. EssilorLuxottica emphasized that Heidelberg Engineering’s expertise in early detection and diagnosis aligns strategically, enhancing its position in the medical technology sector. At the same time, EssilorLuxottica will leverage its global capabilities in logistics, manufacturing, and distribution to support Heidelberg Engineering's vision of creating a shared diagnostic and treatment system, from research to home monitoring. Heidelberg Engineering has always been committed to innovation and quality, with future goals including improving image resolution, expanding imaging technology applications, and integrating AI solutions into its HEYEX medical IT platform. Collaborating with EssilorLuxottica is expected to enhance patient care and clinical outcomes through a comprehensive diagnostic and treatment system.

Founded in 1990, Heidelberg Engineering has become a leader in optical coherence tomography, real-time image processing, analysis, and digital surgical navigation technologies, particularly with its SPECTRALIS and ANTERION platforms. Its business spans over 100 countries, serving medical professionals, scientists, and researchers across a wide range of ophthalmic fields. In subspecialties, Heidelberg Engineering has been a pioneer in the early detection of vision-threatening diseases such as glaucoma and age-related macular degeneration (AMD).

The acquisition of Heidelberg Engineering by EssilorLuxottica marks a significant development in the integration of optical and medical technologies, which is expected to drive advancements in global eye care solutions.